Fabio
96 lines
4.8 KiB
Markdown
96 lines
4.8 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Anti-cancer drugs; analyzing current reimbursement, etc., for medical practices that administer."
|
||
description: "Anti-cancer drugs; analyzing current reimbursement, etc., for medical practices that administer."
|
||
jurisdiction: "us/states/va"
|
||
legislature: "Virginia General Assembly"
|
||
session: "2023"
|
||
identifier: "HB 2200"
|
||
citation: "Virginia HB 2200 (2023)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Robinson"]
|
||
version_count: 4
|
||
action_count: 32
|
||
vote_count: 7
|
||
first_action: "2023-01-11"
|
||
last_action: "2023-03-26"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/7686f958-b03c-408f-a3b7-0463cf240def"
|
||
source_url: "https://lis.virginia.gov/cgi-bin/legp604.exe?231+sum+HB2200"
|
||
source_hash: "8cc024bae16537e5424d1d86f8731269080ddec5a17d9ac8287fdf0bd5030e96"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-va"]
|
||
---
|
||
|
||
# Virginia HB 2200 (2023) — Anti-cancer drugs; analyzing current reimbursement, etc., for medical practices that administer.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **CHAP0582** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?231+ful+CHAP0582)
|
||
2. **Committee substitute printed 23107067D-S1** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?231+ful+HB2200S1)
|
||
3. **HB2200ER** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?231+ful+HB2200ER)
|
||
4. **Prefiled and ordered printed; offered 01/11/23 23103233D** (committee substitute) — [source](https://lis.virginia.gov/cgi-bin/legp604.exe?231+ful+HB2200)
|
||
|
||
## Votes
|
||
|
||
- Reported from Finance and Appropriations with substitute (16-Y 0-N) — **0–0** (fail) · upper
|
||
- VOTE: Passage (63-Y 35-N) — **0–0** (fail) · lower
|
||
- Reported from Finance (14-Y 8-N) — **0–0** (fail) · lower
|
||
- Subcommittee recommends reporting (6-Y 0-N) — **0–0** (fail) · lower
|
||
- VOTE: Adoption (92-Y 0-N) — **0–0** (fail) · lower
|
||
- Passed Senate with substitute (40-Y 0-N) — **0–0** (fail) · upper
|
||
- Constitutional reading dispensed (40-Y 0-N) — **0–0** (fail) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Robinson — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2023-01-11** Prefiled and ordered printed; offered 01/11/23 23103233D `filing, introduction`
|
||
- **2023-01-11** Referred to Committee on Finance `referral-committee`
|
||
- **2023-01-18** Impact statement from DHCD/CLG (HB2200)
|
||
- **2023-01-25** Impact statement from TAX (HB2200)
|
||
- **2023-01-26** Assigned Finance sub: Subcommittee #3 `referral-committee`
|
||
- **2023-01-30** Subcommittee recommends reporting (6-Y 0-N)
|
||
- **2023-02-01** Reported from Finance (14-Y 8-N) `committee-passage`
|
||
- **2023-02-03** Read first time `reading-1`
|
||
- **2023-02-06** Read second time and engrossed `reading-2`
|
||
- **2023-02-07** Read third time and passed House (63-Y 35-N) `passage, reading-3`
|
||
- **2023-02-07** VOTE: Passage (63-Y 35-N) `passage`
|
||
- **2023-02-08** Constitutional reading dispensed
|
||
- **2023-02-08** Referred to Committee on Finance and Appropriations `referral-committee`
|
||
- **2023-02-16** Reported from Finance and Appropriations with substitute (16-Y 0-N) `committee-passage`
|
||
- **2023-02-16** Senate committee, floor amendments and substitutes offered
|
||
- **2023-02-16** Committee substitute printed 23107067D-S1 `substitution`
|
||
- **2023-02-20** Constitutional reading dispensed (40-Y 0-N)
|
||
- **2023-02-21** Read third time `reading-3`
|
||
- **2023-02-21** Reading of substitute waived
|
||
- **2023-02-21** Committee substitute agreed to 23107067D-S1 `substitution`
|
||
- **2023-02-21** Engrossed by Senate - committee substitute HB2200S1 `substitution`
|
||
- **2023-02-21** Passed Senate with substitute (40-Y 0-N) `passage`
|
||
- **2023-02-22** Senate substitute agreed to by House 23107067D-S1 (92-Y 0-N) `substitution`
|
||
- **2023-02-22** VOTE: Adoption (92-Y 0-N)
|
||
- **2023-03-07** Enrolled `enrolled`
|
||
- **2023-03-07** Bill text as passed House and Senate (HB2200ER) `passage`
|
||
- **2023-03-08** Signed by Speaker `passage`
|
||
- **2023-03-08** Signed by President `passage`
|
||
- **2023-03-13** Enrolled Bill communicated to Governor on March 13, 2023 `enrolled, executive-receipt`
|
||
- **2023-03-13** Governor's Action Deadline 11:59 p.m., March 27, 2023 `executive-receipt`
|
||
- **2023-03-26** Approved by Governor-Chapter 582 (effective 7/1/23) `executive-signature`
|
||
- **2023-03-26** Acts of Assembly Chapter text (CHAP0582)
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/7686f958-b03c-408f-a3b7-0463cf240def`. Confidence: reported (aggregated from official Virginia legislature records).
|
||
|